(1S,2R)-2-(4-Fluoro-phenyl)-cyclopropylamine hydrochloride

Catalog No. :
ACJRBS547
CAS No. :
1990505-73-1
Molecular Formula :
C9H11ClFN
Molecular Weight :
187.65

IUPAC Name:(1S,2R)-2-(4-fluorophenyl)cyclopropan-1-amine hydrochloride

(1S,2R)-2-(4-Fluoro-phenyl)-cyclopropylamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$80.00Login to see priceIn stockInquiry
100mg95%$108.00Login to see priceIn stockInquiry
250mg95%$202.00Login to see priceIn stockInquiry
1g95%$469.00Login to see priceIn stockInquiry
5g95%$2342.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1S,2R)-2-(4-Fluoro-phenyl)-cyclopropylamine hydrochloride
IUPAC Name(1S,2R)-2-(4-fluorophenyl)cyclopropan-1-amine hydrochloride
MDL No.MFCD30181877
Molecular FormulaC9H11ClFN
Molecular Weight187.65
SMILESN[C@@H]1[C@@H](C2=CC=C(F)C=C2)C1.[H]Cl
InChI KeyZQPBZLHQLCAFOQ-RJUBDTSPSA-N
Synonym(1S,2R)-2-(4-Fluoro-phenyl)-cyclopropylamine hydrochloride;Cyclopropanamine, 2-(4-fluorophenyl)-, hydrochloride (1:1), (1S,2R)-;Ticagrelor Impurity 74 HCl;Ticagrelor Ticagrelor Impurity 79 HCl;Ticagrelor Impurity 110 HCl
CAS No.1990505-73-1
PubChem CID122460547

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJRBS547 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJRBS547 route product structure diagram
    ACJRBS5471990505-73-1 In Stock
Inquiry

2. ACJRBS547 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJRBS547 route product structure diagram
    ACJRBS5471990505-73-1 In Stock
Inquiry

Comments (0)